Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes

Type 1 diabetes mellitus (T1DM) with obesity is increasingly common, prompting effective clinical interventions to induce weight loss in this population. We present 3 patients with T1DM and obesity prescribed a glucagon-like peptide 1 receptor agonist (GLP-1RA) and pramlintide. Case 1: A 32-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Gunther, Garner, Erica M, Srivastava, Gitanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580416/
https://www.ncbi.nlm.nih.gov/pubmed/37908483
http://dx.doi.org/10.1210/jcemcr/luad040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580416/
https://www.ncbi.nlm.nih.gov/pubmed/37908483
http://dx.doi.org/10.1210/jcemcr/luad040

Ejemplares similares